Similar articles

• [Neuroprotection and vasoprotection in glaucoma].

  Ignat F. Ignat F. Oftalmologia. 2004;48(2):5-14. Oftalmologia. 2004. PMID: 15341092 Romanian. No abstract available.
• European Glaucoma Prevention Study.

  Quigley HA. Quigley HA. Ophthalmology. 2005 Sep;112(9):1642-3; author reply 1643-5. doi: 10.1016/j.ophtha.2005.05.024. Ophthalmology. 2005. PMID: 16139678 No abstract available.
• Glaucoma.

  Shah R, Wormald R. Shah R, et al. Clin Evid. 2002 Jun;(7):589-96. Clin Evid. 2002. Update in: Clin Evid. 2003 Jun;(9):729-36. PMID: 12230685 Updated. Review. No abstract available.
• [The role of Cosopt in glaucoma treatment].

  Călugăru D, Călugăru M. Călugăru D, et al. Oftalmologia. 2008;52(4):15-25. Oftalmologia. 2008. PMID: 19354158 Review. Romanian.
• Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.

  Stewart RM, Clearkin LG. Stewart RM, et al. Am J Ophthalmol. 2008 Jan;145(1):182; author reply 182-3. doi: 10.1016/j.ajo.2007.09.033. Am J Ophthalmol. 2008. PMID: 18154757 No abstract available.